Point of care tests have excessive potential for facilitating faster decision making and consequently more active patient care in the trauma care and emergency department of most hospitals and clinics. The main devices sought after in these sections are used for tests to amount blood gas and electrolyte concentration in the body. This particular segment offers important development opportunities for industry development. In line with this various market players are involved in developments and launch of various PoC diagnostic tests. Moreover, rapid testing through PoC diagnostic technologies is anticipated to decrease the duration of surgical procedures. For example, assessment of blood coagulation status can now be easily observed by bedside testers, reducing the requirement for blood stocking, and nullifying the threat from postoperative blood loss, which is common during complex procedures like heart bypass surgeries. The increase in geriatric population and their susceptibility towards various are augmenting growth of the Point of Care Diagnostics Market. This, joined with the increasing frequency of infectious diseases, is improving the market. The increase in disposable income of people worldwide has invigorated them to opt for better healthcare treatment and facilities. This is further predicted to fuel the demand for Point of Care Diagnostics Market in the coming years.
The point-of-care diagnostics market is expected to be around US$ 67.30 billion by 2028 at a CAGR of 10.4%
The global Point of Care/POC Diagnostics market is segregated on the basis of Mode of Purchase as OTC Products and Prescription-Based Products. Based on End User the global Point of Care/POC Diagnostics market is segmented in Research Laboratories, Professional Diagnostic Centers, Hospitals/Critical Care Centers, Home Care Settings, and Other End Users. Based on Platform the global Point of Care/POC Diagnostics market is segmented in Microfluidics, Molecular Diagnostics, Lateral Flow Assays, Dipsticks, and Immunoassays.
Based on Product, the global Point of Care/POC Diagnostics market is segmented in Cardiometabolic Monitoring Products, Glucose Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, and Drugs-Of-Abuse Testing Products.
The global Point of Care/POC Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Point of Care/POC Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Accubiotech, Instrumentation Laboratory, Nova Biomedical, PTS Diagnostics, Sekisui Diagnostics, Abbott Laboratories, Becton, Dickinson, and Company, Chembio Diagnostics, Danaher Corporation, Johnson & Johnson, and others are among the major players in the global Point of Care/POC Diagnostics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Point of Care/POC Diagnostics Market has been segmented as below:
Point of Care/POC Diagnostics Market, By Mode of Purchase
Point of Care/POC Diagnostics Market, By End User
Point of Care/POC Diagnostics Market, By Platform
Point of Care/POC Diagnostics Market, By Product
Point of Care/POC Diagnostics Market, By Region
Point of Care/POC Diagnostics Market, By Company
The report covers:
Report Scope:
The global Point of Care/POC Diagnostics market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Point of Care/POC Diagnostics market share. Major industry players with significant revenue share include Accubiotech, Instrumentation Laboratory , Nova Biomedical, PTS Diagnostics, Sekisui Diagnostics, Abbott Laboratories, Becton, Dickinson, and Company , Chembio Diagnostics, Danaher Corporation, Johnson & Johnson, and others.
Reasons to Buy this Report:
Some of the recent developments in Point of Care/POC Diagnostics Market are as follows:
Abbott Laboratories
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Personal and Homecare Robotics Market
mobile applications for melanoma detection market
1. Introduction
1.1. Key Take Aways
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
5. Point of Care Diagnostics Market, By Product
5.1. Key Points
5.2. Tumor/Cancer Marker Testing Products
5.3. Urinalysis Testing Products
5.4. Cholesterol Testing Products
5.5. Hematology Testing Products
5.6. Drugs-of-abuse Testing Products
5.7. Fecal Occult Testing Products
5.8. Other POC Products
5.9. Pregnancy & Fertility Testing Products
5.10. Coagulation Monitoring Products
5.11. Infectious Disease Testing Products
5.12. Cardiometabolic Monitoring Products
5.13. Glucose Monitoring Products
6. Point of Care Diagnostics Market, By Mode of Purchase
6.1. Key Points
6.2. OTC Products
6.3. Prescription-based Products
7. Point of Care Diagnostics Market, By End-User
7.1. Key Points
7.2. Home Care Settings
7.3. Hospitals/Critical Care Centers
7.4. Clinical Laboratories and Outpatient Healthcare & Ambulatory Care Settings
7.5. Other End Users
8. Point of Care Diagnostics Market, By Platform
8.1. Key Points
8.2. Microfluidics
8.3. Molecular Diagnostics
8.4. Immunoassays
8.5. Lateral Flow Assays
8.6. Dipsticks
9. Point of Care Diagnostics Market, By Region
9.1. Key Points
9.2. North America
9.2.1. U.S
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Spain
9.3.2. Russia
9.3.3. Turkey
9.3.4. Belgium
9.3.5. Netherlands
9.3.6. Germany
9.3.7. France
9.3.8. Italy
9.3.9. Rest of Europe
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Australia
9.4.5. Rest of Asia Pacific
9.5. Rest of World
9.6. Competitive Landscape
9.7. Introduction
9.8. Recent Developments
9.8.1. Mergers & Acquisitions
9.8.2. New Product Developments
9.8.3. Portfolio/Production Capacity Expansions
9.8.4. Joint Ventures, Collaborations, Partnerships & Agreements
9.8.5. Others
10. Company Profile
10.1. Sekisui Diagnostics
10.1.1. Company Overview
10.1.2. Product/Service Landscape
10.1.3. Financial Overview
10.1.4. Recent Developments
10.2. PTS Diagnostics
10.2.1. Company Overview
10.2.2. Product/Service Landscape
10.2.3. Financial Overview
10.2.4. Recent Developments
10.3. Nova Biomedical
10.3.1. Company Overview
10.3.2. Product/Service Landscape
10.3.3. Financial Overview
10.3.4. Recent Developments
10.4. Instrumentation Laboratory
10.4.1. Company Overview
10.4.2. Product/Service Landscape
10.4.3. Financial Overview
10.4.4. Recent Developments
10.5. Accubiotech
10.5.1. Company Overview
10.5.2. Product/Service Landscape
10.5.3. Financial Overview
10.5.4. Recent Developments
10.6. Trinity Biotech
10.6.1. Company Overview
10.6.2. Product/Service Landscape
10.6.3. Financial Overview
10.6.4. Recent Developments
10.7. Quidel
10.7.1. Company Overview
10.7.2. Product/Service Landscape
10.7.3. Financial Overview
10.7.4. Recent Developments
10.8. EKF Diagnostics
10.8.1. Company Overview
10.8.2. Product/Service Landscape
10.8.3. Financial Overview
10.8.4. Recent Developments
10.9. Siemens Healthineers Group
10.9.1. Company Overview
10.9.2. Product/Service Landscape
10.9.3. Financial Overview
10.9.4. Recent Developments
10.10. Roche Diagnostics
10.10.1. Company Overview
10.10.2. Product/Service Landscape
10.10.3. Financial Overview
10.10.4. Recent Developments
10.11. Johnson & Johnson
10.11.1. Company Overview
10.11.2. Product/Service Landscape
10.11.3. Financial Overview
10.11.4. Recent Developments
10.12. Danaher Corporation
10.12.1. Company Overview
10.12.2. Product/Service Landscape
10.12.3. Financial Overview
10.12.4. Recent Developments
10.13. Chembio Diagnostics
10.13.1. Company Overview
10.13.2. Product/Service Landscape
10.13.3. Financial Overview
10.13.4. Recent Developments
10.14. Becton, Dickinson, and Company
10.14.1. Company Overview
10.14.2. Product/Service Landscape
10.14.3. Financial Overview
10.14.4. Recent Developments
10.15. Abbott Laboratories
10.15.1. Company Overview
10.15.2. Product/Service Landscape
10.15.3. Financial Overview
10.15.4. Recent Developments
The Point of Care/POC Diagnostics Market has been segmented as below:
Point of Care/POC Diagnostics Market, By Mode of Purchase
Point of Care/POC Diagnostics Market, By End User
Point of Care/POC Diagnostics Market, By Platform
Point of Care/POC Diagnostics Market, By Product
Point of Care/POC Diagnostics Market, By Region
Point of Care/POC Diagnostics Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
